Addus HomeCare (NASDAQ:ADUS) executives said a new federal moratorium on certain home health licenses should have little effect on the company’s growth plans, while highlighting continued improvement in personal care services trends and ongoing acquisition opportunities.
Speaking at an RBC healthca
Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived thr...
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and...
What Happened? A number of stocks fell in the afternoon session after the April PPI report showed wholesale inflation accelerating to 6% annually, with servi...
Over the past six months, Addus HomeCare’s shares (currently trading at $98.51) have posted a disappointing 11.1% loss, well below the S&P 500’s 10% gain. Th...
Addus HomeCare’s first quarter results were met with a negative market reaction, largely due to revenue falling short of Wall Street’s expectations despite h...
What Happened? Shares of home healthcare provider Addus HomeCare (NASDAQ:ADUS) fell 4.6% in the afternoon session after the company reported first-quarter fi...
Home healthcare provider Addus HomeCare (NASDAQ:ADUS) fell short of the market’s revenue expectations in Q1 CY2026, but sales rose 7.7% year on year to $363....
Home healthcare provider Addus HomeCare (NASDAQ:ADUS) missed Wall Street’s revenue expectations in Q1 CY2026, but sales rose 7.7% year on year to $363.6 mill...
Home healthcare provider Addus HomeCare (NASDAQ:ADUS) will be reporting earnings this Monday afternoon. Here’s what to expect. Addus HomeCare met analysts’ r...
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have seen decent returns lat...
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However,...
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Addus HomeCare (NASDAQ:ADUS) and the best and worst performers in the senior health, home health & hospice industry.
Home healthcare provider Addus HomeCare (NASDAQ:ADUS) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 25.6% year on year to $373.1 million. Its non-GAAP profit of $1.77 per share was 2.6% above analysts’ consensus estimates.
